CVS Group plc Director/PDMR and PCA Shareholding (6955J)

TIDMCVSG

RNS Number : 6955J

CVS Group plc

06 December 2018

CVS Group plc

("CVS" or the "Company")

Director/PDMR and PCA Shareholding

CVS, the veterinary services group, announces that it was notified on 5 December 2018 that on 5 December 2018, Richard Connell, Chairman of the Company, purchased 10,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares").

As a result, Mr Connell holds 120,000 Ordinary Shares, representing 0.17 per cent of the total voting rights of the Company. Mr Connell's total interest in the Company, including his wife's holding, is now 120,000 Ordinary Shares, representing 0.17 per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                         Richard Connell 
      ---------------------------  ----------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------- 
 a)    Position/status              Chairman 
      ---------------------------  ----------------------------------------- 
 b)    Initial notification         Initial Notification 
        /Amendment 
      ---------------------------  ----------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------- 
 a)    Name                         CVS Group plc 
      ---------------------------  ----------------------------------------- 
 b)    LEI                          213800J41XDQ2NX48O05 
      ---------------------------  ----------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------- 
 a)    Description of the           Ordinary shares of 0.2 pence each 
        financial instrument, 
        type of instrument 
                                     GB00B2863827 
        Identification code 
      ---------------------------  ----------------------------------------- 
 b)    Nature of the transaction    On-market purchase 
      ---------------------------  ----------------------------------------- 
 c)    Price(s) and volume(s)         Price(s)   Volume(s) 
                                       616.00     5,000 
                                                 ---------- 
                                       616.00     5,000 
                                                 ---------- 
      ---------------------------  ----------------------------------------- 
 
       Aggregated information 
 
        - Aggregated volume           10,000 
 
 
 d)     - Price                       616.00 
      ---------------------------  ----------------------------------------- 
 e)    Date of the transaction      5 December 2018 
      ---------------------------  ----------------------------------------- 
 f)    Place of the transaction     London Stock Exchange - AIMX 
      ---------------------------  ----------------------------------------- 
  Contacts:                                         Tel: [phone] 
   CVS Group plc                                     288 
   Simon Innes, Chief Executive 
   Richard Fairman, Finance Director 
 N+1 Singer (Nominated Adviser & Broker)           Tel: [phone] 
  Aubrey Powell , Jennifer Boorer                   3000 
  Rachel Hayes 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFMMGZMVLGRZM

(END) Dow Jones Newswires

December 06, 2018 06:41 ET (11:41 GMT)